Larotrectinib User Reviews & Ratings
Brand names: Vitrakvi
Condition | Avg. Rating | Reviews | Compare |
---|---|---|---|
Solid Tumors | 1 reviews for Solid Tumors | 14 medications | |
Add your review |
Reviews may be edited to correct grammar/spelling or to remove inappropriate language and content. Reviews that appear to be created by parties with a vested interest are not published. This information is not intended to endorse any particular medication. While these reviews may be helpful, they are not a substitute for the expertise, knowledge, and judgement of healthcare professionals.
More about larotrectinib
- Check interactions
- Compare alternatives
- Reviews (1)
- Latest FDA alerts (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: multikinase inhibitors
- Breastfeeding
- En español
Vitrakvi (larotrectinib) for Solid Tumors "I've only been taking Vitrakvi a couple months, for squamous cell cancer in left head and neck after already having chemo and radiation , with no fresh scans I can't say anything about effectiveness but I'm not expecting much of a turn around if at all , mainly because of negative prognosis. But I can say I haven't had any bad side effects , but I didn't with chemo either, lucky I guess. No nausea or anything like that so I would say don't concern over that . Good luck. Thank you Bayer very much for the opportunity ."